Teladoc Health, Inc. TDOC

Latest FY: 2025 Healthcare Health Information Services
Market Price $6.08
Market Cap $1.10B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.5% YoY
$2.53B
3-Yr CAGR: 1.7%
Net Income ↑80.0% YoY
-$200.32M
Net Margin: -7.9%
Free Cash Flow ↑0.9% YoY
$285.46M
FCF Yield: 26.01%
EPS (Diluted) ↑80.6% YoY
$-1.14
Basic: $-1.14
Return on Equity Efficiency
-14.5%
ROA: -7.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TDOC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $123.2M $91.2M $-74.2M 0.00% $-51.9M $-54.0M
FY 2017 $233.3M +89.4% $171.7M $-106.8M -43.9% 0.00% $-34.4M $-37.1M +31.3%
FY 2018 $417.9M +79.1% $289.2M $-97.1M +9.1% 0.00% $-4.9M $-8.9M +76.1%
FY 2019 $553.3M +32.4% $368.8M $-98.9M -1.8% $-1.38 0.00% $29.9M $26.4M +397.1%
FY 2020 $1,094.0M +97.7% $703.1M $-485.1M -390.7% $-5.36 -288.4% 0.00% $-53.5M $-57.5M -318.3%
FY 2021 $2,032.7M +85.8% $1,382.4M $-428.8M +11.6% $-2.73 +49.1% 0.00% $194.0M $185.5M +422.3%
FY 2022 $2,406.8M +18.4% $1,662.9M $-13,659.5M -3,085.6% $-84.60 -2,998.9% 0.00% $189.3M $172.8M -6.8%
FY 2023 $2,602.4M +8.1% $1,842.4M $-220.4M +98.4% $-1.34 +98.4% 0.00% $350.0M $338.6M +95.9%
FY 2024 $2,569.6M -1.3% $1,818.3M $-1,001.2M -354.4% $-5.87 -338.1% 0.00% $293.7M $282.9M -16.4%
FY 2025 $2,530.0M -1.5% $1,758.4M $-200.3M +80.0% $-1.14 +80.6% 0.00% $294.4M $285.5M +0.9%
$

Valuation

Market Price $6.08
Market Cap $1.10B
Enterprise Value $316.44M
P/E Ratio N/A
P/B Ratio 0.79
FCF Yield 26.01%
Dividend Yield N/A
Shares Outstanding 180,513,100
%

Profitability & Margins

Gross Margin 69.50%
Operating Margin -10.39%
Net Margin -7.92%
Return on Equity (ROE) -14.46%
Return on Assets (ROA) -7.01%
Asset Turnover 0.89x
Revenue 3-Yr CAGR 1.68%
🛡️

Financial Health & Liquidity

Current Ratio 2.77
Cash Ratio 1.93
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $781.08M
Total Debt N/A
Book Value / Share $7.68
💧

Cash Flow Efficiency

Operating Cash Flow $294.36M
Capital Expenditures (CapEx) $8.89M
Free Cash Flow $285.46M
OCF / Revenue 11.63%
FCF / Revenue 11.28%
FCF 3-Yr CAGR 18.21%
🏷️

Per Share Metrics

EPS (Diluted) $-1.14
EPS (Basic) $-1.14
Dividends / Share N/A
Book Value / Share $7.68
EPS YoY Growth 80.58%
🏛️

Balance Sheet (FY 2025)

Total Assets $2.86B
Total Liabilities $1.47B
Stockholders' Equity $1.39B
Current Assets $1.12B
Current Liabilities $404.74M